Melola Discovery

← Melola Discovery

Jurnal Tanpa peringkat SINTA

Development Michrosphere Bioadhesive Delivery System From Secondary Metabolit Actynomycetes M10a Rhizosphere Mangrove As Supportive Therapy of Colon Cancer Patients

International Journal of Applied Biology · Vol. 2 No. 1 (2018) · hlm. 55–60

ISSN
2580-2119, 2580-2410
Terbit
2018-07-28
Penerbit
Hasanuddin University
Bahasa
en

Abstrak

Colon cancer is a cancer that occurs in the large intestine when abnormal cells grow in the colon or rectum layer. Inflammation Symptoms in the colon are usually characterized by a polyp that has cancer risk. Approximately 96% of colon cancer cases are caused by adenocarcinomas that develop from the glandular tissue. Utilization of secondary metabolites from Actynomycetes Mangrove forests can be used as supportive therapy for colon cancer patients that have already through apoptotic testing so it can directly treat the target of illness. This study was prepared in the form of Michrosphere Bioadhesive using secondary metabolite Actynomycetes M10a rhizosphere mangrove. The purpose of this study was to obtain the development of Michosphere Bioadhesive preparations from secondary metabolites Actynomycetes M10a rhizosphere mangrove as supportive therapy for colon cancer patients. Method of the research is base on Laboratory experiment which started with Purification of Actynomycetes isolate, Secondary Metabolite Fermentation, Michrosphere Bioadhesive Formulation and evaluation of Michrosphere Bioadhesive preparation. The concentration of secondary metabolite Actynomycetes M10a rhizosphere mangrove that been used for each formula are 400 μl, 500 μl, and 600 μl, where the percentage of submerged in F1, F2, and F3 are 93,94%, 96,96%, and 94, respectively, 12%. Particular Particle Size Distribution is F1 (3.1μm), F2 (4.4 μm), F3 (3.9 μm). The rest angles obtained are F1 (0.002O), F2 (0.002O), F3 (0.0016O), respectively. Applied efficiency was obtained by F1 (214 nm), F2 (210 nm), F3 (211 nm). Dissolution results show the absorbance results at 266 nm wavelength. From the results obtained that meet the specifications seen in Formula 2. Keywords: Colon Cancer, Actynomycetes M10a rhizosphere mangrove, Michosphere Bioadhesive.

Jaringan kolaborasi para penulis

Belum ada rekan penulis di Melola.

Sumber metadata: OAI-PMH (metadata jurnal) https://journal.unhas.ac.id/index.php/ijoab/oai, pertama di-harvest 3 Nov 2026, terakhir terlihat 15 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Development Michrosphere  Bioadhesive Delivery System From Secondary  Metabolit Actynomycetes M10a Rhizosphere  Mangrove As Supportive Therapy of Colon Cancer  Patients</dc:title>
	<dc:creator xml:lang="en">Basri, Fajrin Hasan</dc:creator>
	<dc:description xml:lang="en">Colon cancer is a cancer that occurs in the large intestine when abnormal cells grow in the colon or rectum layer.  Inflammation Symptoms  in the colon are usually characterized by a polyp that has cancer risk. Approximately 96% of colon cancer cases are caused by adenocarcinomas that develop from the glandular tissue. Utilization of secondary metabolites from Actynomycetes Mangrove forests can be used as supportive therapy for colon cancer patients that have already through apoptotic testing so it can directly treat the target of illness. This  study was prepared in the form of  Michrosphere Bioadhesive  using secondary metabolite  Actynomycetes M10a rhizosphere mangrove. The purpose of this study was to obtain the development of  Michosphere Bioadhesive  preparations from secondary metabolites  Actynomycetes M10a  rhizosphere mangrove  as supportive therapy for colon cancer patients. Method of the research is base on Laboratory experiment which started with Purification  of  Actynomycetes  isolate, Secondary Metabolite Fermentation,  Michrosphere Bioadhesive  Formulation and evaluation of  Michrosphere  Bioadhesive  preparation. The concentration of secondary metabolite Actynomycetes M10a rhizosphere mangrove that been used for each formula are 400 μl, 500 μl, and 600 μl, where the percentage of submerged in F1, F2, and F3 are 93,94%, 96,96%, and 94, respectively, 12%. Particular Particle Size Distribution is F1 (3.1μm), F2 (4.4 μm), F3 (3.9 μm). The rest angles obtained are F1 (0.002O), F2 (0.002O), F3 (0.0016O), respectively. Applied efficiency was obtained by F1 (214 nm), F2 (210 nm), F3 (211 nm). Dissolution results show the absorbance results at 266 nm wavelength. From the results obtained that meet the specifications seen in Formula 2.  Keywords: Colon Cancer,  Actynomycetes  M10a  rhizosphere mangrove, Michosphere Bioadhesive.</dc:description>
	<dc:publisher xml:lang="en">Hasanuddin University</dc:publisher>
	<dc:date>2018-07-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.unhas.ac.id/index.php/ijoab/article/view/4615</dc:identifier>
	<dc:source xml:lang="en">International Journal of Applied Biology; Vol. 2 No. 1 (2018): International Journal of Applied Biology; 55-60</dc:source>
	<dc:source>2580-2119</dc:source>
	<dc:source>2580-2410</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://journal.unhas.ac.id/index.php/ijoab/article/view/4615/2664</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2018 International Journal of Applied Biology</dc:rights>
</oai_dc:dc>